Domestic price of Pazopanib

Pazopanib is used to treat kidney cancer and some other cancers (soft tissue sarcomas). Pazopanib is a tyrosine kinase inhibitor. Its working principle is to reduce the amount of blood provided to tumors to slow down the growth of tumors. Pazopanibshould not be used in children, especially children under 2 years of age, due to the risk of serious side effects. Some other effects are approved that are not listed on the drug label, but may be prescribed by your doctor. A common dose for adults with renal cell carcinoma is 800 mg taken at least 1 hour before or 2 hours after meals until disease progression or unacceptable toxicity occurs. The systemic exposure of pazopanib may be increased when pazopanib is taken with food. Administration of pazopanib with a high-fat (approximately 50% fat) or low-fat (approximately 5% fat) meal resulted in an approximately 2-fold increase in AUC and Cmax.

PazopanibThe original drug has been launched in China and has entered the scope of Class B medical insurance, but reimbursement is limited to patients who meet the indications. The price of each box may be around RMB 3,000. The reimbursement ratio is different in different regions, and the price after reimbursement may be different. The price of pazopanib original drug specifications200mg*30 tablets marketed overseas may be around 1,000 RMB per box (the price may fluctuate due to exchange rates). There are also pazopanib generic drugs produced in other countries. The price of 200mg*30 tablets produced by Bangladesh pharmaceutical factory may be around 500 yuan per box (the price may fluctuate due to the exchange rate), which is cheaper. The pharmaceutical ingredients of generic drugs are basically the same as those of domestic and foreign original drugs.